Hospital 'guardedly optimistic' during cancer drug shortage
OKLAHOMA CITY (KFOR) - A cancer drug called Vincristine is in short supply, and that's leaving many families concerned.
"It is fundamentally important to curing children with many of the common cancers we see in children, the most common of these, acute lymphoblastic leukemia, we cannot cure without the use of Vincristine," said Dr. William Meyer, chief of pediatric hematology-oncology at the OU Children's Hospital.
It's also important to the people who took time to sign a petition that is going around the internet, calling on the government to step in.
The Children's Oncology Group put out a letter with recommendations on what doctors can do.
"We've taken several steps. We've looked at what our present supply is, we've reached out to all the suppliers, we have very carefully evaluated our patient population who will need this drug over the next month," Meyer said.
He says the Children's Hospital should have enough supply for the next month.
Right now, only one company, Pfizer, makes Vincristine. In a statement, they say, "We have scaled up production to fully meet the need for Vincristine over the long term. we have also expedited additional shipments of Vincristine, which are now in transit to healthcare providers so they can treat patients."
"We are guardedly optimistic that we will have enough drug," Meyer said.
Drug company Teva stopped making the drug in March because of what they call a lack of demand. They say in a statement, "With the data that was available, there was no indication of a possibility of a shortage if the company left the market and availability of Teva product has not contributed to the shortage that is being experienced today."
Going forward, this is something experts don't want to ever see happen in the future.
"One of the things that has been suggested is we create a stockpile of some of these critically needed drugs so if there are problems from the manufacturing standpoint, we have a supply that we have put away and saved to meet these what are usually short term shortages," Meyer said.
There is no alternative drug to Vincristine. According to the FDA, the next expected delivery is the end of the month.
More News in Cancer
Johnson & Johnson a voluntary recall of its talc-based baby powder products on Friday, after the Food and Drug Administration found traces of cancer-causing asbestos in sample testing. The recall
The French drug maker Sanofi said Friday it would be voluntarily recalling Zantac in the U.S. and Canada, as the Food and Drug Administration investigates a potentially dangerous contaminant detected in the drug. The company
An artificial intelligence tool that was trained on about a million mammography images is able to identify breast cancer with 90 percent accuracy combined with analysis by radiologists. These results were derived in a study by
A woman who was diagnosed with a rare form of breast cancer early in her pregnancy has given birth to a healthy baby. Doctors in Loma Linda, California warned that Jade Devis, 36, would have a
Jade Devis of Rancho Cucamonga, California, was only a few weeks into her pregnancy when she was diagnosed with a rare form of cancer - one that, doctors initially told her, meant that her baby
A French pharmaceutical company is recalling heartburn drug Zantac after the U.S. Food and Drug Administration found it contained unsafe levels of a chemical linked to cancer. Sanofi, the latest pharmaceutical firm to pull the drug,